Hellman S, Weichselbaum RR (1995) Oligometastases. J Clin Oncol 13:8–10. https://doi.org/10.1200/JCO.1995.13.1.8

Article  CAS  PubMed  Google Scholar 

Guckenberger M, Lievens Y, Bouma AB et al (2020) Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation. Lancet Oncol 21:e18–e28. https://doi.org/10.1016/S1470-2045(19)30718-1

Article  PubMed  Google Scholar 

Lievens Y, Guckenberger M, Gomez D et al (2020) Defining oligometastatic disease from a radiation oncology perspective: an ESTRO-ASTRO consensus document. Radiother Oncol 148:157–166. https://doi.org/10.1016/j.radonc.2020.04.003

Article  PubMed  Google Scholar 

Dingemans AC, Hendriks LEL, Berghmans T et al (2019) Definition of synchronous oligometastatic non-small cell lung cancer: a consensus report. J Thorac Oncol 14:2109–2119. https://doi.org/10.1016/j.jtho.2019.07.025

Article  PubMed  Google Scholar 

Kinj R, Muggeo E, Schiappacasse L et al (2022) Stereotactic body radiation therapy in patients with oligometastatic disease: clinical state of the art and perspectives. Cancers (Basel) 14:1152. https://doi.org/10.3390/cancers14051152

Article  CAS  PubMed  Google Scholar 

Palma DA, Olson R, Harrow S et al (2019) Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet 393:2051–2058. https://doi.org/10.1016/S0140-6736(18)32487-5

Article  PubMed  Google Scholar 

Palma DA, Olson R, Harrow S et al (2020) Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial. J Clin Oncol 38:2830–2838. https://doi.org/10.1200/JCO.20.00818

Article  PubMed  PubMed Central  Google Scholar 

Khoo V, Kirby A, Ahmed M et al (2023) CORE - Standard of care +/- stereotactic body radiotherapy for oligometastases: primary results. Radiother Oncol 182:s627. https://doi.org/10.1016/S0167-8140(23)08702-9

Article  Google Scholar 

Schellenberg D, Gabos Z, Duimering A et al (2025) Stereotactic ablative radiation for oligoprogressive cancers: results of the randomized phase 2 STOP trial. Int J Radiat Oncol Biol Phys 121:28–38. https://doi.org/10.1016/j.ijrobp.2024.08.031

Article  PubMed  Google Scholar 

Palma DA, Olson R, Harrow S et al (2019) Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial. BMC Cancer 19:816. https://doi.org/10.1186/s12885-019-5977-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Olson R, Mathews L, Liu M et al (2020) Stereotactic ablative radiotherapy for the comprehensive treatment of 1–3 oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial. BMC Cancer 20:380. https://doi.org/10.1186/s12885-020-06876-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thureau S, Marchesi V, Vieillard MH et al (2021) Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III trial (STEREO-OS). BMC Cancer 21:117. https://doi.org/10.1186/s12885-021-07828-2

Article  PubMed  PubMed Central  Google Scholar 

Gomez DR, Blumenschein GR Jr, Lee JJ et al (2016) Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study. Lancet Oncol 17:1672–1682. https://doi.org/10.1016/S1470-2045(16)30532-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gomez DR, Tang C, Zhang J et al (2019) Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study. J Clin Oncol 37:1558–1565. https://doi.org/10.1200/JCO.19.00201

Article  CAS  PubMed  PubMed Central  Google Scholar 

Iyengar P, Wardak Z, Gerber DE et al (2018) Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: a phase 2 randomized clinical trial. JAMA Oncol 4:e173501. https://doi.org/10.1001/jamaoncol.2017.3501

Article  PubMed  Google Scholar 

Iyengar P, Hu C, Gomez DR et al (2024) Randomized phase II/III trial of maintenance systemic therapy versus local consolidative therapy (LCT) plus maintenance systemic therapy for limited metastatic non-small cell lung cancer (NSCLC). J Clin Oncol 42(16_suppl):850. https://doi.org/10.1200/JCO.2024.42.16_suppl.8506

Article  Google Scholar 

Wang XS, Bai YF, Verma V et al (2023) Randomized trial of first-line tyrosine kinase inhibitor with or without radiotherapy for synchronous oligometastatic EGFR-mutated non-small cell lung cancer. J Natl Cancer Inst 115(6):742–748. https://doi.org/10.1093/jnci/djac015

Article  CAS  PubMed  Google Scholar 

Tsai CJ, Yang JT, Shaverdian N et al (2024) Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (consolidative use of radiotherapy to block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study. Lancet 403(10422):171–182. https://doi.org/10.1016/S0140-6736(23)01857-3

Article  PubMed  Google Scholar 

Weiss J, Kavanagh B, Deal A et al (2019) Phase II study of stereotactic radiosurgery for the treatment of patients with oligoprogression on erlotinib. Cancer Treat Res Commun 19:100126. https://doi.org/10.1016/j.ctarc.2019.100126

Article  PubMed  Google Scholar 

Iyengar P, Kavanagh BD, Wardak Z et al (2014) Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer. J Clin Oncol 32:3824–3830. https://doi.org/10.1200/JCO.2014.56.7412

Article  PubMed  Google Scholar 

Conibear J, Chia B, Ngai Y et al (2018) Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer. BMJ Open 8:e020690. https://doi.org/10.1136/bmjopen-2017-020690

Article  PubMed  PubMed Central  Google Scholar 

Bahig H, Tonneau M, Blais N et al (2022) Stereotactic ablative radiotherapy for oligo-progressive disease refractory to systemic therapy in non-small cell lung cancer: a registry-based phase II randomized trial (SUPPRESS-NSCLC). Clin Transl Radiat Oncol 33:115–119. https://doi.org/10.1016/j.ctro.2021.12.008

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pons-Tostivint E, Kirova Y, Lusque A et al (2020) Radiation therapy to the primary tumor for de novo metastatic breast cancer and overall survival in a retrospective multicenter cohort analysis. Radiother Oncol 145:109–116. https://doi.org/10.1016/j.radonc.2019.12.019

Article  PubMed  Google Scholar 

Staren ED, Salerno C, Rongione A et al (1992) Pulmonary resection for metastatic breast cancer. Arch Surg 127:1282–1284. https://doi.org/10.1001/archsurg.1992.01420110024006

Article  CAS  PubMed  Google Scholar 

McDonald ML, Deschamps C, Ilstrup DM et al (1994) Pulmonary resection for metastatic breast cancer. Ann Thorac Surg 58:1599–1602. https://doi.org/10.1016/0003-4975(94)91639-x

Article  CAS  PubMed  Google Scholar 

Simpson R, Kennedy C, Carmalt H et al (1997) Pulmonary resection for metastatic breast cancer. Aust N Z J Surg 67:717–719. https://doi.org/10.1111/j.1445-2197.1997.tb07116.x

Article  CAS  PubMed  Google Scholar 

Friedel G, Pastorino U, Ginsberg RJ et al (2002) Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the International Registry of Lung Metastases. Eur J Cardiothorac Surg 22:335–344. https://doi.org/10.1016/s1010-7940(02)00331-7

Article  PubMed  Google Scholar 

Vlastos G, Smith DL, Singletary SE et al (2004) Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases. Ann Surg Oncol 11:869–874. https://doi.org/10.1245/ASO.2004.01.007